(Q24235315)

1

0 references

Anna Bersano

2

0 references

Livia Candelise

3

0 references

Brent A Reynolds

4

0 references

Eugenio A Parati

Cochrane Database of Systematic Reviews

5

0 references

publication date

8 September 2010

0 references

published in

0 references

cites work

Potential roles of bone marrow stem cells in stroke therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Cell therapy of brain stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Transplantation of cultured human neuronal cells for patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Cell transplantation therapy for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Treatment of neural injury with marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Stem cells for the treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

21 January 2018

Cell therapy for stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Cell therapy: replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

European Stroke Initiative Recommendations for Stroke Management – Update 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

Autologous mesenchymal stem cell transplantation in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Neural stem cells and their use as therapeutic tool in neurological disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007231.PUB2